| . | Scenario 1a . | Scenario 1b . | Scenario 2a . | Scenario 2b . | Scenario 2c . | Scenario 3 . |
|---|---|---|---|---|---|---|
| Age groups vaccinated | 70+ | 70+ | 70+ | 70+ | 70+ | 30–69 |
| Healthcare professionals vaccinated | No | Yes | No | Yes | Yes | Yes, included in the age groups |
| Prioritization amongst the selected groups | Vaccine doses administered parallelly | Vaccine doses administered parallelly | Starting from 90+, to 80+ and 70+ | Starting from 90+, to 80+ and 70+; HC parallelly | Starting with HC, then 90+, 80+ and 70+ | Vaccine doses administered parallelly |
| Uptake rate | 80% | 80% | 80% | 80% | 80% | 30–59: 50% 60–69: 70% |
| Vaccine doses available | ∼21.17 million | |||||
| Capacity (doses per day) | 100,000 | |||||
| . | Scenario 1a . | Scenario 1b . | Scenario 2a . | Scenario 2b . | Scenario 2c . | Scenario 3 . |
|---|---|---|---|---|---|---|
| Age groups vaccinated | 70+ | 70+ | 70+ | 70+ | 70+ | 30–69 |
| Healthcare professionals vaccinated | No | Yes | No | Yes | Yes | Yes, included in the age groups |
| Prioritization amongst the selected groups | Vaccine doses administered parallelly | Vaccine doses administered parallelly | Starting from 90+, to 80+ and 70+ | Starting from 90+, to 80+ and 70+; HC parallelly | Starting with HC, then 90+, 80+ and 70+ | Vaccine doses administered parallelly |
| Uptake rate | 80% | 80% | 80% | 80% | 80% | 30–59: 50% 60–69: 70% |
| Vaccine doses available | ∼21.17 million | |||||
| Capacity (doses per day) | 100,000 | |||||
HC, healthcare professionals.
| . | Scenario 1a . | Scenario 1b . | Scenario 2a . | Scenario 2b . | Scenario 2c . | Scenario 3 . |
|---|---|---|---|---|---|---|
| Age groups vaccinated | 70+ | 70+ | 70+ | 70+ | 70+ | 30–69 |
| Healthcare professionals vaccinated | No | Yes | No | Yes | Yes | Yes, included in the age groups |
| Prioritization amongst the selected groups | Vaccine doses administered parallelly | Vaccine doses administered parallelly | Starting from 90+, to 80+ and 70+ | Starting from 90+, to 80+ and 70+; HC parallelly | Starting with HC, then 90+, 80+ and 70+ | Vaccine doses administered parallelly |
| Uptake rate | 80% | 80% | 80% | 80% | 80% | 30–59: 50% 60–69: 70% |
| Vaccine doses available | ∼21.17 million | |||||
| Capacity (doses per day) | 100,000 | |||||
| . | Scenario 1a . | Scenario 1b . | Scenario 2a . | Scenario 2b . | Scenario 2c . | Scenario 3 . |
|---|---|---|---|---|---|---|
| Age groups vaccinated | 70+ | 70+ | 70+ | 70+ | 70+ | 30–69 |
| Healthcare professionals vaccinated | No | Yes | No | Yes | Yes | Yes, included in the age groups |
| Prioritization amongst the selected groups | Vaccine doses administered parallelly | Vaccine doses administered parallelly | Starting from 90+, to 80+ and 70+ | Starting from 90+, to 80+ and 70+; HC parallelly | Starting with HC, then 90+, 80+ and 70+ | Vaccine doses administered parallelly |
| Uptake rate | 80% | 80% | 80% | 80% | 80% | 30–59: 50% 60–69: 70% |
| Vaccine doses available | ∼21.17 million | |||||
| Capacity (doses per day) | 100,000 | |||||
HC, healthcare professionals.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
